Activity of azithromycin against Mycobacterium avium infection in beige mice
- 1 August 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (8) , 1611-1613
- https://doi.org/10.1128/aac.36.8.1611
Abstract
The comparative activities of azithromycin and clarithromycin and the activities of azithromycin alone and in combination with other antimycobacterial agents were evaluated in the beige mouse model of disseminated Mycobacterium avium complex infection. Azithromycin was similar in activity to clarithromycin. Azithromycin plus clofazimine plus ethambutol reduced the number of splenic organisms more than azithromycin alone, while the combination was less active than azithromycin alone for bacteria in lungs. Rifabutin had activity similar to that of azithromycin for organisms in spleens and lungs. Rifabutin plus azithromycin was more active than either agent alone for organisms in spleens, but the combination's activity was not significantly different from that of rifabutin for organisms in lungs. The activity of azithromycin against several M. avium complex isolates was evaluated. The reduction of viable cell counts in spleens ranged from 1.7 to 0.8 log units. For the three isolates studied, there was little correlation between the in vitro MIC and the in vivo activity.Keywords
This publication has 11 references indexed in Scilit:
- Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDSThe Lancet, 1991
- In vivo activities of newer rifamycin analogs against Mycobacterium avium infectionAntimicrobial Agents and Chemotherapy, 1991
- Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige miceAntimicrobial Agents and Chemotherapy, 1990
- In vitro and in vivo activities of clarithromycin against Mycobacterium aviumAntimicrobial Agents and Chemotherapy, 1989
- In vitro activities of several new macrolide antibiotics against Mycobacterium avium complexAntimicrobial Agents and Chemotherapy, 1989
- Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige miceAntimicrobial Agents and Chemotherapy, 1989
- In Vitro and In Vivo Activity of Azithromycin (CP 62,993) Against the Mycobacterium avium ComplexThe Journal of Infectious Diseases, 1989
- Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distributionAntimicrobial Agents and Chemotherapy, 1987
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987
- Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1985